Beat COVID-19 - Observational Trial
NCT04337762 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2020-04-09
Summary
JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients with COVID-19. We aim to accomplish this by obtaining self-reported historical and longitudinal data from study participants.
Conditions
Sponsors & Collaborators
-
Beat COVID LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-06
- Primary Completion
- 2020-12-31
- Completion
- 2021-07-31
Countries
- United States
Study Locations
More Related Trials
-
Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments
NCT05638932 ·Status: COMPLETED
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Study in Patients With Mild to Moderate COVID-19
NCT05374772 ·Status: UNKNOWN
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
NCT07076862 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
NCT04373148 ·Status: COMPLETED
-
Developement and Evaluation of Serological Assays for COVID-19
NCT04377763 ·Status: UNKNOWN
-
Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project
NCT05463380 ·Status: RECRUITING
-
International SARS-CoV-2 (COVID-19) Infection Observational Study
NCT04385251 ·Status: COMPLETED
-
C-reactive Protein Levels Among Individuals With COVID-19
NCT04373798 ·Status: COMPLETED
-
COVID-19 Contact Study by Antigen Detection Test
NCT04745533 ·Status: WITHDRAWN
-
Leflunomide in Mild COVID-19 Patients
NCT04361214 ·Status: TERMINATED ·Phase: PHASE1
-
COVID-19 Observational Research Collaboratory
NCT05394025 ·Status: COMPLETED
-
Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry
NCT04347278 ·Status: UNKNOWN
-
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
NCT04371471 ·Status: COMPLETED
-
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
NCT04333589 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Evaluation of COVID-19 Diagnostic Tests
NCT04337996 ·Status: COMPLETED ·Phase: NA
-
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
NCT04324047 ·Status: UNKNOWN
-
The COVID-19 PUI Reality Check (CPRC) Study
NCT04474288 ·Status: COMPLETED
-
An Observational Study in Patients With Mild to Moderate COVID-19
NCT05366244 ·Status: UNKNOWN
-
COVID Cohort Study
NCT04393155 ·Status: TERMINATED
-
Immunophenotyping Assessment in a COVID-19 Cohort
NCT04378777 ·Status: COMPLETED
-
Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults
NCT04341168 ·Status: UNKNOWN